BioLineRx Ltd. (BLRX)

BioLineRx Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	66	97	36	96	50	22
Market Cap Growth	48.74%	167.89%	-62.36%	93.60%	123.00%	-51.38%
Enterprise Value	49	66	-2	44	35	5
PE Ratio	-	-1.60	-1.45	-3.56	-1.66	-0.88
PS Ratio	5.69	20.26	-	-	-	-
PB Ratio	5.08	7.35	0.71	1.42	2.26	0.67
P/FCF Ratio	-2.82	-4.28	-1.38	-4.07	-2.15	-0.98
P/OCF Ratio	-2.83	-4.30	-1.38	-4.09	-2.15	-0.99
EV/Sales Ratio	4.25	13.72	-	-	-	-
EV/EBITDA Ratio	-1.43	-1.15	0.11	-1.73	-1.27	-0.24
EV/EBIT Ratio	-1.37	-1.13	0.11	-1.69	-1.23	-0.23
EV/FCF Ratio	-2.23	-2.90	0.09	-1.86	-1.50	-0.23
Debt / Equity Ratio	0.87	0.88	0.24	0.07	0.35	0.31
Debt / EBITDA Ratio	-0.25	-0.20	-0.56	-0.18	-0.28	-0.47
Debt / FCF Ratio	-0.39	-0.51	-0.47	-0.20	-0.33	-0.46
Quick Ratio	1.00	1.03	4.85	5.89	2.14	2.35
Current Ratio	1.14	1.10	4.87	5.91	2.15	2.36
Asset Turnover	0.21	0.08	0	0	0	0
Interest Coverage	-21.64	-26.95	-10.56	-25.89	-17.43	-10.18
Return on Equity (ROE)	-325.10%	-280.20%	-44.10%	-39.00%	-114.80%	-63.50%
Return on Assets (ROA)	-86.50%	-99.20%	-33.20%	-31.50%	-62.10%	-42.30%
Return on Capital (ROIC)	-187.33%	-200.27%	-46.16%	-34.06%	-77.16%	-64.13%
Earnings Yield	-74.07%	-62.33%	-68.73%	-28.05%	-60.26%	-113.91%
FCF Yield	-43.43%	-23.37%	-72.64%	-24.54%	-46.58%	-101.76%
Buyback Yield / Dilution	-17.73%	-24.47%	-16.75%	-162.19%	-72.70%	-34.82%
Total Shareholder Return	-17.73%	-24.47%	-16.75%	-162.19%	-72.70%	-34.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).